Roche, Ascletis To Collaborate On Hepatitis C Drug In China
This article was originally published in PharmAsia News
Executive Summary
Roche and Ascletis have entered into a collaboration to develop and commercialize Roche's investigational drug danoprevir (RG7227) in China for the treatment of hepatitis C, Roche said in a press release.